The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

Journal of Neurochemistry

Volumn 76, Issue 1, 2001, Pages 87-96

  Campbell, Bruce C V ^a,b   McLean, Catriona A ^a,b   Culvenor, Janetta G ^a,b   Gai, Wei Ping ^c   Blumbergs, Peter C ^d   Jäkälä, Pekka ^e,f   Beyreuther, Konrad ^e   Masters, Colin L ^a,b   Li, Qiao Xin ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

synuclein; Dementia with Lewy bodies; Multiple system atrophy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; DETERGENT;

ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MOLECULAR WEIGHT; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PONS; PRIORITY JOURNAL; PROTEIN PROCESSING; SHY DRAGER SYNDROME; SOLUBILITY; WHITE MATTER;

AGED; ALPHA-SYNUCLEIN; BLOTTING, WESTERN; BRAIN CHEMISTRY; CEREBELLUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FRONTAL LOBE; HUMANS; LEWY BODY DISEASE; MIDDLE AGED; MOLECULAR WEIGHT; MULTIPLE SYSTEM ATROPHY; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA; PARKINSON DISEASE; PONS; REFERENCE VALUES; SODIUM DODECYL SULFATE; SOLUBILITY; SYNUCLEINS;

EID: 0035163412     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00021.x     Document Type: Article

References (36)

1. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
2. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
3. Survival of patients with pathologically proven multiple system atrophy: A meta-analysis
4. Accumulation of insoluble α-synuclein in dementia with Lewy bodies
5. Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited: NAC and α-synuclein are not associated with Aβ amyloid
6. Tan and synuclein and their role in neuropathology
7. Widespread alterations of α-synuclein in multiple system atrophy
8. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments
9. Consensus statement on the diagnosis of multiple system atrophy
10. α-synuclein in Lewy body disease and Alzheimer's disease
11. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
12. Identification of two distinct synucleins from human brain
13. Amyloid diseases: Abnormal protein aggregation in neurodegeneration
14. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
15. The synuclein family
16. Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzbeimer's disease precursor protein in the hippocampus of aged transgenic mice
17. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
18. Amyloid plaque core protein in Alzheimer disease and Down syndrome
19. Myelin degeneration in multiple system atrophy detected by unique antibodies
20. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
21. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
22. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content
23. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
24. α-Synuclein shares physical and functional homology with 14-3-3 proteins
25. Antibodies against peripheral myelin glycolipids in people with HIV infection
26. Mutation in the α-synuclein gene identified in families with Parkinson's disease
27. Novel proteinaceous infectious particles cause scrapie
28. α-synuclein in Lewy bodies
29. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
30. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders
31. Contribution of somal Lewy bodies to neuronal death
32. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia
33. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
34. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
35. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
36. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease